Halozyme Therapeutics shares owned by UBS O'Connor
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.4M | 25k | 57.24 |
| 2024-03-31 | $2.4M | 60k | 40.68 |
| 2023-09-30 | $2.6M | 69k | 38.20 |
| 2023-06-30 | $136k | 109k | 1.25 |
| 2023-03-31 | $2.7M | 70k | 38.19 |
| 2022-12-31 | $3.3M | 57k | 56.89 |
| 2022-09-30 | $3.3M | 84k | 39.54 |
| 2022-06-30 | $3.9M | 88k | 44.00 |
| 2022-03-31 | $3.0M | 75k | 39.88 |